Hemoglobin Testing Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Japan, China, India, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2014 – 2025
Report ID: GMI3667
Hemoglobin Testing Market size is projected to experience significant growth from 2019 to 2025.
Growing number of anemia and thalassemia patients across the globe will stimulate global hemoglobin testing business growth in the forecast period. As per the National Ambulatory Medical Care Survey, in 2016, about 2.8 million Americans were affected by anemia. Additionally, growing prevalence of thalassemia will further lead to high demand for hemoglobin testing devices market.
Growing preference for home-care treatment among anemia and thalassemia patients will be a major factor for growth of hemoglobin testing market growth in the future. Moreover, various market players are focusing on development of hand-held and point-of-care hemoglobin analyzers, thereby leading to market growth in the future. Development of advanced techniques providing quick results and ease-of-use will further boost market growth in the future.
Fluoroscopy devices segment will hold a significant revenue size over the forecast years owing to various associated advantages such as portability, optical magnification and radiation sensitivity among others. Additionally, wide array of applications of fluoroscopy devices such as angiography, image-guided biopsy and discography will boost the segment growth.
Point-of-care hemoglobin testing devices will witness steady growth during the forecast timeframe. Various advantages associated with POC devices such as accurate and quick results coupled with low cost of diagnosis will boost market growth. Moreover, various market players are focusing on development of advanced and novel POC hemoglobin testing devices, thus leading to segmental growth.
Immunoassay segment is expected to shoe lucrative growth during the analysis period. High growth rate is attributed to low cost of testing compared to other diagnosis methods. Additionally, high sensitivity of immunoassay technique gives accurate and precise results, thus boosting segment growth in the future.
Hospitals segment will show considerable growth during the projected timeframe. Growing prevalence of anemia and thalassemia coupled with increasing demand for diagnostic procedures will boost market growth in hospitals. Additionally, development of healthcare infrastructure will offer growth opportunities to drive the segmental growth.
North America hemoglobin testing market will dominate the overall market during the forecast period due to rise in the number of diagnostic centers for the detection of hemoglobin levels and diagnosis of various hemoglobinopathies. Additionally, growing prevalence of thalassemia and other chronic blood disorders will boost regional growth. Also, the favorable regulatory policies to ensure patient safety will boost the U.S. hemoglobin testing industry growth over forthcoming years.
Asia Pacific hemoglobin testing market is estimated to witness lucrative growth over the forecast period due to unmet medical needs and rising prevalence and incidence of diabetes. Moreover, rising government investment that supports growth of healthcare infrastructure across the developing economies of the region will spur market growth.
Few of the key companies operating in hemoglobin testing market include Abbott Laboratories, ACON Laboratories, Bio-Rad Laboratories, Danaher, EKF Diagnostics Holdings, F. Hoffmann-La Roche, Nova Biomedical, Quest Diagnostics, Sysmex Corporation and Wrig Nanosystems Pvt. Ltd. The industry players focus on strategic initiatives such as new product launch and mergers and acquisitions to maintain their market position.
Hemoglobin Testing Market by Product, 2014-2025 (USD Million)
- Automated hematology analyzers
- Reagents and Consumables
Hemoglobin Testing Market by Technology, 2014-2025 (USD Million)
Hemoglobin Testing Market by End-use, 2014-2025 (USD Million)
- Diagnostic Centers
- Homecare Settings
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- Abbott Laboratories
- ACON Laboratories
- Bio-Rad Laboratories
- EKF Diagnostics Holdings
- F. Hoffmann-La Roche
- Nova Biomedical
- Quest Diagnostics
- Sysmex Corporation
- Wrig Nanosystems Pvt. Ltd.
What Information does this report contain?
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability